| Nervonic acid attenuates accumulation of very long-chain fatty acids and is a potential therapy for adrenoleukodystrophy MR Terluk, J Tieu, SA Sahasrabudhe, A Moser, PA Watkins, GV Raymond, ... Neurotherapeutics 19 (3), 1007-1017, 2022 | 17 | 2022 |
| Population pharmacokinetic analysis of N‐acetylcysteine in pediatric patients with inherited metabolic disorders undergoing hematopoietic stem cell transplant SA Sahasrabudhe, RV Kartha, M Ng, LM Basso, U Mishra, JC Cloyd, ... The Journal of Clinical Pharmacology 61 (12), 1638-1645, 2021 | 4 | 2021 |
| Identifying biological signatures of n-acetylcysteine for non-suicidal self-injury in adolescents and young adults SA Sahasrabudhe, T Silamongkol, YW Park, A Colette, LE Eberly, ... Journal of psychiatry and brain science 6, 2021 | 4 | 2021 |
| N-acetylcysteine pharmacology and applications in rare diseases—Repurposing an old antioxidant SA Sahasrabudhe, MR Terluk, RV Kartha Antioxidants 12 (7), 1316, 2023 | 3 | 2023 |
| Physiologically‐Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug–Drug Interactions SA Sahasrabudhe, S Cheng, M Al‐Kofahi, JR Jarnes, NJ Weinreb, ... Clinical Pharmacology & Therapeutics 112 (6), 1254-1263, 2022 | 2 | 2022 |
| Biological variation in peripheral inflammation and oxidative stress biomarkers in individuals with Gaucher disease SA Sahasrabudhe, MR Terluk, KD Rudser, JC Cloyd, RV Kartha International journal of molecular sciences 23 (16), 9189, 2022 | 2 | 2022 |
| Translational and clinical pharmacology considerations in drug repurposing for X‐linked adrenoleukodystrophy—A rare peroxisomal disorder JH Tieu, SA Sahasrabudhe, PJ Orchard, JC Cloyd, RV Kartha British Journal of Clinical Pharmacology 88 (6), 2552-2563, 2022 | 2 | 2022 |
| Repeated-dose oral n-acetylcysteine in Gaucher disease: Pharmacokinetics summary J Roh, S Sahasrabudhe, U Mishra, MR Terluk, J Cloyd, L Coles, ... Molecular Genetics and Metabolism 141 (2), 108020, 2024 | | 2024 |
| Pharmacokinetic comparability between two populations using nonlinear mixed effect models: a Monte Carlo study SA Sahasrabudhe, PL Bonate Journal of Pharmacokinetics and Pharmacodynamics 50 (3), 189-201, 2023 | | 2023 |
| IDENTIFYING BIOLOGICAL SIGNATURES OF NON-SUICIDAL SELF INJURY: A PHASE II, DOUBLE BLIND, RANDOMIZED, CONTROLLED TRIAL. S Sahasrabudhe, R Kartha, J Cloyd, L Coles, L Eberly, Y Park, G Oz, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 111, S75-S75, 2022 | | 2022 |
| Neurofilament light chain: A potential marker of neurological disease in Gaucher disease MR Terluk, SA Sahasrabudhe, K Rudser, RV Kartha Molecular Genetics and Metabolism 135 (2), S118-S119, 2022 | | 2022 |
| Application of Clinical Pharmacology in Rare Diseases and Non-suicidal Self-injury SA Sahasrabudhe University of Minnesota, 2022 | | 2022 |
| Modeling potential interactions between oral Gaucher disease treatment and investigational COVID-19 therapies SA Sahasrabudhe, M Al-Kofahi, JC Cloyd, N Weinreb, RV Kartha Molecular Genetics and Metabolism 132 (2), S93, 2021 | | 2021 |
| Population Pharmacokinetic Analysis of N-acetylcysteine in Pediatric Patients with Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplant S Siddhee, K Reena, CJC Ng M, O PJ, B RC, C LD ACoP11 2 (ISSN:2688-3953), 2020 | | 2020 |
| Effect of Experimentally Induced Gliadin Enteropathy on Expression and Metabolic Activity of Hepatic CYP2C11 in Wistar Rats SA Sahasrabudhe Massachusetts College of Pharmacy and Health Sciences, 2018 | | 2018 |
Reena KarthaUniversity of MinnesotaVerified email at umn.edu
